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Nerve system diseases like Parkinson’s disease, Huntington's disease and Alzheimer's disease 
etc. seriously affect thousands of patients’ lives every year, making the patients suffer from 
pains and inconvenience brought about by these diseases. Recently, bio-interface between 
neural cells/tissues and polymer based biomaterials  attracted  worldwide attention due to the 
ability of polymer based biomaterials to serve as nerve conduits, drug carrier and neurites 
guidance platform in neuroregeneration. The role that bio-interface played and the way it 
interacted with neural tissues and cells have been thoroughly investigated by the researchers. 
In this paper we mainly focus on reviewing bio-interface between nerve tissues/cells and 
advanced functional biocompatible polymers, such as conducting polymers and advanced 
carbon composites materials.. These advanced polymers can provide combined interfacial 
stimulations including interfacial NTFs delivery, electrical stimulation, surface guidance and 
molecules decoration to lesion cells and tissues to promote neuroregeneration in vitro and in 
vivo, and have contributed greatly to nerve diseases therapy. At the end of this review, the 
criteria of polymer based biomaterials utilized in neuroregeneration are summarized and the 
perspectives for future development of bio-interfaces are also discussed.  
1. Introduction 
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The nerve system is a complex and sophisticated system that regulates and coordinates body 
activities. The nerve system is vulnerable to various external and internal influences and can 
be damaged by multiple reasons, such as trauma, infection, degeneration, blood flow 
disruption and autoimmune disorders[1]. These damages may cause serious nerve system 
diseases, such as spinal cord injury, Parkinson’s disease (PD)[2], Huntington's disease (HD)[3] 
and Alzheimer's disease(AD)[4] etc., which affect thousands of peoples’ lives every year and 
bring deep sufferings to human beings.  
The therapies for these diseases attracted a broad range of attention worldwide from local 
communities to the research industry as they are expected to relieve the patients’ suffering to 
some extent.  The nerve system diseases currently can be treated in hospital by doctors in 
neurology, neurological surgery and rehabilitation department via medicine, surgery and 
physical methods for nerve system recovery. Meanwhile, huge attention has been paid by 
global researchers on more effective neuroregeneration methods to enhance nerve system 
diseases therapy[5].  
To understand the importance of neuroregeneration, the pathogenesis of neural diseases and 
how neuroregeneration approaches influence neural tissues/cells should be discussed. The 
neural system is constituted of two major parts, the central nervous system (CNS) which 
consists of the spinal cord and brain, and the peripheral nervous system (PNS) which consists of 
all other neural elements according to their different functions [6]. Most neural system diseases 
are caused by damages to the CNS, including spinal cord injury (SCI) and brain damage. 
Spinal cord injury is a major cause of disability. The functional decline of SCI is contributed 
to by both direct mechanical injury and secondary pathophysiological mechanisms that are 
induced by the initial trauma. These mechanisms initially involve widespread haemorrhage at 
the site of injury and necrosis of the central nervous system (CNS) cellular components. At 
later stages of injury, the cord is observed to display reactive gliosis. The actions of astrocytes 
as well as numerous other cells in this response create an environment that is highly 
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nonpermissive to axonal regrowth. This affects the communication between the PNS and the 
brain  and finally leads to disability [7].   
Meanwhile, damage to the brain, including neurotropic viral infections, stroke, paraneoplastic 
disorders, traumatic brain injury and multiple sclerosis[8], which can trigger slow and 
progressive dysfunction and loss of neurons and axons in the CNS, is the primary pathological 
feature of acute and chronic neurodegenerative conditions such as AD, PD and HD. For 
example, in Alzheimer’s disease, characteristic dementia is attributed to widespread 
degeneration of cerebral cortical neurons and secondary cholinergic differentiation; in 
Parkinson’s disease, the classic hypokinetic movement disorder seems to result from loss of 
modulatory dopaminergic input to the striatum from the substantia nigra; and in Huntington’s 
disease, loss of striatal output neurons leads to the motor, cognitive, and affective 
abnormalities that are characteristic of this disease [9].  
Evidence suggests that the brain, like many other tissues, is in a state of dynamic equilibrium. 
It has an endogenous population of neuronblast that proliferate in response to environmental 
and pharmacological manipulations and that can replace cells lost in some experimental 
lesions [10]. The adult rodent brain generates neuronal progenitor cells in the subventricular 
zone (SVZ) and in the dentate gyrus of the hippocampus throughout life. The persistence of 
neurogenesis in the adult mammalian brain suggests that endogenous precursors are a source 
for neuronal replacement after brain injury. After stroke in the adult brain, the neuroblast 
population is greatly expanded in the SVZ, and these cells are recruited to areas bordering the 
infarct, where they can differentiate into neurons and thereby replace lost neurons[11]. 
Although the expansion of neuroblast population may help to promote the neuroregenerative 
process, the fact remains that neurodegenerative disorders such as AD, PD and HD are 
characterized by continuous loss of neurons that are not replaced, which means that a primary 
deficit in neural stem-cell proliferation; migration, or differentiation, or both, might contribute 
to net cell loss and neuronal circuit disruption in these disorders. This claim, supported by 
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work with animals, proposes that failure of endogenous neural stem cells to respond 
appropriately and replace neurons lost to neurodegenerative disease might be a further 
common mechanism that contributes to functional compromise[12]. Therefore, promoting 
neuroregeneration via multiple approaches, such as stimulating neurogenesis, to generate 
regenerative neurons to replace lesion neurons and axons can be a common method for neural 
system diseases treatments.  
Neuroregeneration, as a fast growing area dedicated to new methods to recover nerve 
functionality after injury in treatment, refers to the regrowth or reconstruction of nerve cells, 
tissues or cell products via multiple stimulation methods to nerve cells or tissues[10].  
Polymers have controllable interfacial, physical and chemical properties, micro- and nano-
processable abilities, as well as tunable conductivities to make them ideal platform materials 
for neuroregeneration[13]. The development of advanced biocompatible polymers afforded 
more possibilities in neuroregeneration by offering multiple interfacial stimulations for 
neuroregeneration, including providing external neurotrophic factors (NTFs) to the nerve 
injury site directly or by novel cyto-compatible scaffolds to stimulate cells biologically[14-17], 
using nerve conduits at lesion gaps as templates to guide nerve neurites growth and 
stimulating cells via various cues such as topographical cues[18-21], electrical cues[22] and 
physical cues[23-25]. The realization of these stimulations is more determined by the surface 
properties of the polymers and the interactions between cells/tissues and polymer surfaces 
rather than the bulk properties of biopolymers.  
Polymers can provide interfacial stimulations to nerve cells/tissues in the following ways: 1) 
Interfacial NTFs delivery: biodegradable polymers (poly(DL-lactide)co-glycolide (PLGA)[14, 
15], poly(ε-caprolactone) (PCL)[16], polyL-lactic  acid (PLLA)[17]etc.) are ideal platforms 
materials for interfacial delivery of NTFs to abnormal tissues in various neural disease 
treatments; 2) Interfacial surface guidance: processable biopolymers can be fabricated into 
aligned structures at different scales, including nanofibers[26-28], microfibers[18,19], 
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microlines[20,21] and micro-tunnels[29,30], to influence interfacial interactions between neural 
cells/tissues and surfaces; 3) Interfacial electrical stimulation (ES): ES could be applied on the 
surface of nerve cells via biocompatible conducting polymers (CPs) platforms to enhance 
nerve cell proliferation and neurites outgrowth[22]; 4) Interfacial molecules decoration: 
multiple biomolecules and proteins can be decorated  onto the surfaces of polymer scaffolds 
to improve the adhesion and growth of nerve cells[31]; 5) Combined interfacial stimulations: 
recent research revealed that the combinations of these stimulation methods can further 
improve the interfacial interactions between lesion cells/tissues and polymer based 
biomaterials, as well as the effects of nerve diseases treatments [29, 32].  
The studies of using polymers in neuroregeneration started from traditional biopolymers, such 
as PLGA[29,33], polyglycolic acid (PGA)[34], polylactic acid (PLA)[35] etc, due to their ability to 
provide interfacial NTFs delivery to lesion nerve tissue/cells and their biocompatibility. 
However, this simple and monotonous stimulation method cannot fulfil the developing 
requirements for multiple and combined stimulations in neuroregeneration. CPs, as possible 
candidates to resolve this question, were investigated widely in this area as platform materials 
for neuroregeneration. Firstly, CPs are conductive and thus can provide interfacial ES to nerve 
tissue/cells seeded on them. Secondly, CPs can provide controlled interfacial NTFs delivery 
by incorporating NTFs as dopants in polymer chains to realize a controllable long-term 
interfacial NTFs delivery. In addition, other biomolecules for cell adhesion or further 
modification can also be incorporated into CPs as dopants. Moreover, most CPs are 
processable and thus can be fabricated into various structures, including microtubes, 
microlines, microfibers and nanofibers, to provide interfacial surface guidance to neuron 
tissues/cells. Therefore, CPs can be considered as the most suitable platform materials for 
their ability to combine multiple interfacial stimulations. 
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In this paper all kinds of stimulations that traditional polymers and CPs can provide will be 
reviewed and compared for their advantages and disadvantages. Bio-interface effects of 
traditional synthetic and natural biodegradable polymers, e.g. PLGA, PLA, chitosan, would be 
only briefly reviewed for their limitations discussed above. The most recent progress of the 
applications of functional materials (CPs, carbon nanotubes (CNTs), graphene, etc.) in 
neuroregeneration and their interfacial properties will be focused upon and reviewed in detail. 
The criteria and prospectivity of the bio-interface of polymer based biomaterials will also be 
discussed.  
2. Bio-interface of traditional Biopolymers in Neuroregeneration 
The earliest utilization of polymers in neuroregeneration was aroused by the increasing needs 
for delivering NTFs and guiding neurites growth at lesion site in nerve disease therapy. 
PLGA, a synthetic biodegradable polymer, which was used as a drug carrier in other disease 
treatments[36, 37], was firstly introduced by Camarata et al. to neuroregeneration. 
Biodegradable PLGA microspheres were used to deliver nerve growth factor (NGF) in both in 
vitro and in vivo experiments to nerve cells and brain tissues [14]. NGF can be released to a 
lesion site over a relatively long period with the degradation of PLGA. Results demonstrated 
that NGF loaded PLGA microspheres showed a continuous release into both cell culture 
medium and rat brain over a prolonged period of time and led to neurite outgrowth. This 
material is processable and the release period of NTFs can vary from weeks to years by 
controlling the preparation conditions and the ratio of lactide and glycolide in the polymer 
chains [38]. 
PLGA, together with polymers with similar structures (PLA, PGA), have been studied over a 
relatively long period and been verified as bio-safe in both in vivo and in vitro experiments, 
and have already been approved by the Food and Drugs Administration (FDA) for 
commercial use in clinical applications [39].  Most of these materials are soluble and can be 
formed into multi-scale morphologies, e.g. microspheres and micro-tunnels, to provide 
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interfacial support to neural cells/tissues while providing NTFs. Also, natural biodegradable 
polymers including chitosan and alginate can perform similar functions and work 
independently or together with synthetic polymers as drug delivery platforms or nerve 
conduits. 
Although the advantages of these traditional biopolymers are quite apparent, disadvantages of 
these synthetic polymers cannot be neglected either. The first disadvantage of synthetic 
biodegradable polymers is that the incorporation efficiency of proteins is low because of the 
degradation of NTFs due to the harsh synthetic conditions. In addition, PLGA and most other 
synthetic biodegradable polymers, such as PLLA, PCL, poly (hydroxybu- tyrate) (PHB) [40] 
etc., are hydrophobic, which limits their use in tissue engineering due to their poor cell 
adhesion abilities. 
To overcome these harsh synthetic conditions and cell adhesion issues, some water soluble 
and hydrophilic natural biodegradable polymers, such as chitosan [29, 41], collagen and alginate 
etc. [35], were introduced into neuroregeneration to provide a similar interfacial NTFs delivery 
service as PLGA. In comparison with synthetic polymers like PLGA, these polymers can be 
prepared under more gentle conditions from aqueous solutions, which are extraordinarily 
beneficial to keep the bioactivities of NTFs proteins. However, the interfacial NTFs delivery 
provided by natural biopolymers (Chitosan, Collagen) is not as controllable as synthetic 
polymers (PLGA, PLLA, PLA). When used in NTFs delivery, there often occurred a burst 
release in the initial several hours during the release period, thus it is hard to maintain a long 
period sustainable protein release.  
Therefore, a series of composites and structures were designed to combine the advantages of 
both types of biopolymers with enhanced interfacial properties, cell adhesion ability and 
NTFs delivery ability to promote neurites’ surface interaction with NCs for clinical translation 
[35, 42]. Hyaluronic acid (HA) is a natural biopolymer which showed distinct advantages for 
neural repair by preventing glial scar formation, inducing endogenous neurons migration in 
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the gel [30]. To introduce interfacial NTFs delivery ability into a HA scaffold, PLGA 
microspheres loaded with brain-derived neurotrophic factors (BDNF) and vascular endothelial 
growth factors (VEGF) were incorporated into the HA scaffold to mimic the in vivo 
environment in nerve repair[29]. Experimental results showed that the hydrogel composite 
containing BDNF and VEGF shows a significant effect on neural stem cells (NSCs) 
proliferation in comparison with particle-free HA scaffold (Figure 1). 
Besides composite materials, special structures were also designed to promote interfacial 
neurites guidance together with NTFs delivery. The most often used structure in 
neuroregeneration made from traditional biopolymers were nerve conduits (NCs). NCs are 
tubular structures that are used to bridge the gap of a severed nerve, by acting as a guide for 
the regenerating neurites and as a barrier against the ingrowth of scar-forming tissue (Figure 
2). Polymer NCs have been made of various materials of biologic (vein, alginate and 
chitosan) or synthetic origin (PLGA, PLA, silicone and poly(hydroxbutyrate)), as reviewed in 
several publications [43-46]. Depending on the material, NCs can be commonly produced by 
melt extrusion, dip coating, casting, or depositing material on a rotating mandrel. Typical NC 
dimensions for experimental use in small animals are inner diameters of 1–2 mm and lengths 
of several millimetres, depending on the experimental gap length [47]. The most often studied 
polymer NCs have been reviewed in a paper published by Pfister etc. [44] (Table 1). 
Madduri etc. fabricated thermal cross-linked collagen NCs by using spinning mandrel 
technology loaded with glial cell line-derived neurotrophic factor (GDNF) and NGF (Figure 
2). NCs were coated with several layers of PLGA after fabrication. The release of the 
neurotrophic factors was sustained for over 30 days and remained biologically active, as  
confirmed by an in vitro bioassay using chicken embryonic dorsal root ganglion (DRG) 
explants[53].This method protected the bioactivity of NTFs by trapping NTF proteins in 
collagen and preventing fast release of NTFs by coating a PLGA layer outside.  
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PLGA NCs filled with collagen sponge successfully provided adequate scaffolding for nerve 
tissue extension to serve as a connective guide across a 15mm gap in the left peroneal nerve 
(Figure 3). In comparison with autografting, this composite nerve conduit enabled superior 
functional recovery and shortened recovery period [54]. 
In summary, the employment of traditional polymers, including synthetic polymers (PLGA, 
PLLA, PLA) and natural biopolymers (chitosan, collagen, HA), successfully achieved the 
target of providing effective interfacial NTFs delivery to severed nerves in neuroregeneration. 
In addition, special NCs structures made from these polymers can also provide interfacial 
guidance at lesion gaps for nerve functional recovery. However, traditional polymers cannot 
provide interfacial ES to nerve tissues/cells due to their being insulators. Another limitation of 
traditional polymers is that NTFs contained in these polymers were passively released with 
time. The release period may be adjusted by the structure of the polymer, but a more accurate 
“release on demand” system cannot be created based on these polymers. The relatively simple 
and monotonous chemical structures made further surface modification very difficult too. 
More complicated systems that can provide combined interfacial stimulations were strongly 
needed to enhance neuroregeneration efficiency.  
3. Bio-interface of CPs in Neuroregeneration 
An electrophysiology study in the late nineteenth century suggested that neurons in the nerve 
system transferred information through bioelectrical signals [55]. Since then, the influence of 
external ES on the nerve system has been investigated in a series of studies[56] in the mid-
twentieth century and it has been proven that electrical charges play an important role in 
stimulating either the proliferation or differentiation of various cell types[57]. Also extensive 
research both in vitro and in vivo has shown that electromagnetic fields play an important role 
in neurite extension and regeneration of transected nerve ends [58].  
These findings led researchers to think about introducing conductive platform materials to 
neuroregeneration in order to provide interfacial ES directly to nerve tissues/cells instead of 
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external stimulation in cell/tissue culture medium[58]. In addition, a conductive scaffold is 
more suitable for implantation to provide ES in vivo from a clinical perspective.  
These conductive platform materials could be semi-conductors such as silicon, metals and 
CPs. In comparison with other conductive or semi-conductive platforms (metal, silicon), CPs 
showed their specific advantages in neuroregeneration. CPs were softer and more stretchable 
than metal or silicon[59], which can not only promote cell adhesion on their surfaces, but can 
also be beneficial for the implantation device. Also, CPs demonstrated low impedence and 
recorded better signals compared to metal, and thus were often used as the modification layer 
in nerve probe applications[60]. In addition, their semi-conductive property helped CPs 
platforms to avoid exorbitant current stimulation that may kill nerve tissues/cells[58]. The 
needs in neuroregeneration for conductive platforms and the merits that CPs had over other 
candidates made CPs to be chosen by researchers for investigations as platform materials in 
neuroregeneration.  
3.1. CPs 
Until about 30 years ago, all carbon based polymers were rigidly regarded as insulators.  In 
1977, it was found that polyacetylene could be rendered conductive by doping [61]. Since then, 
a series of conductive polymers, including polyaniline (PANi), polypyrrole (PPy) and 
polythiophenes such as poly(3,4-ethylenedioxythiophene) (PEDOT) (Figure 4),  have been 
widely investigated and applied in various areas including neuroregeneration. 
CPs are organic polymers that can conduct electricity due to the π–π coupling structure in the 
polymer chains. Charges can transfer through these specific conjugated structures and showed 
comparable conductivity to semiconductors. The interfacial, physical, chemical, and 
electrochemical properties (conductivity and impedance) of CPs can be fine-tuned by 
synthesizing polymers under different polymerization conditions. In addition, CPs also 
exhibited electrochemical activity and redox properties when doped with various ions. 
Furthermore, most CPs are soluble and processable, and thus can be fabricated into different 
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topographies and patterns with enhanced interfacial properties to serve as tissue engineering 
scaffolds.  
3.2. Compatibility of CPs 
Biocompatibility is the key issue which determines whether a material can serve in tissue 
engineering or not. The in vitro and in vivo compatibility of CPs has already been proven by 
researchers in a series of experiments. For example, a study on PPy in nerve tissue 
engineering utilizes electrochemically synthesized PPy films to evaluate the biocompatibility 
of materials [62]. Experimental results demonstrated that PPy can support the adhesion and 
growth of L929 mouse fibroblast and neuro2a neuroblastoma cells in vitro. In an in vivo 
experiment, there was only a minimal tissue response after PPy was implanted into a rat 
model for 4 weeks. Studies also demonstrated that PPy is compatible with nerve cell and 
tissue when applying ES, [22, 62] although some evidence of toxicity was reported after long 
term large current stimulation (e.g. 1mA, 96h [62]). Also, some evidences showed PANi is 
compatible in vitro to several cell lines including PC 12 and H9c2 cardiac myoblasts [63] and 
in vivo after implantation [64]. 
3.3. Interfacial ES of CPs in Neuroregeneration 
After being verified as biocompatible, PPy was firstly reported by the C.E Schimidt group in 
an application as a neuroregeneration scaffold in 1997[22]. In Schimidt’s study, PPy film was 
electrochemically coated on ITO glass and used as substrates for PC 12 cell culture. PC 12 
cells attached and extended well on PPy films in comparison with PLA and PLGA. The 
conductivity of the film was detected to be ~ 10 S/cm. A 100 mV potential was applied to PPy 
films for nerve cell stimulation in vitro to study the influence of ES on neurite extension. 
Results showed that PC 12 cells cultured on PPy films and subjected to ES through the film 
underwent a significant increase in neurite lengths compared to the ones that were not 
subjected to ES through the film (Figure 5). The median neurite length for PC 12 cells grown 
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on PPy and subjected to an electrical stimulus was 18.14 μm (n = 5643) compared with 9.5 
μm (n = 4440) for controls. 
Since then, a series of approaches have been developed to enhance nerve regeneration 
efficiency of CPs by combining electrical, biological and topographical stimulations together 
in one scaffold to promote the interaction between scaffold and neural cells/tissues. 
3.4. Interfacial molecules decoration of CPs in Neuroregeneration 
To improve the surface interaction between CPs and nerve tissues/cells and enhance 
neuroregeneration efficiency, a series of biomolecules were decorated on CPs’ polymer 
chains to tune the physical, chemical and interfacial properties of CPs. For example, the 
incorporation of NTFs can promote neurons proliferations and axons extension while the 
modification of other proteins (collagen, laminin etc.) can help to improve cell adhesion 
properties. Furthermore, some other dopant molecules, such as CS, HA, heparin dextran 
sulphate, can adjust hardness, roughness, modulus of CPs for further implantation in vivo. In 
addition, the combined utilization of these biomolecules in CPs became a trend in most recent 
research work. 
3.4.1. Incorporation of NTFs into CPs 
3.4.1.1. Entrapment of NTFs in CPs via Electrical Deposition 
The most typical method of incorporating NTFs in CPs is the entrapment method. NTFs and 
monomers were mixed together in solution with supporting dopants and then followed by 
electrochemical deposition on a conductive substrate. NTFs were trapped in CPs film during 
this procedure. When ES was applied, a redox reaction occurred on the CPs films which led to 
the release of NTFs with dopants into the environment.  
The G. G. Wallace group firstly studied the possibility of incorporation of neurotrophin-3 
(NT-3) into PPy film using an electrical deposition method in 2006. The loading capacity and 
amount of NT-3 released from the polymer was determined using 125I-labelled NT-3 under 
various electrochemical conditions. Electrochemical stimulation of PPy by pulsed voltage, 
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pulsed current and CV all promoted the release rate of NT-3 compared to passive release of 
NT-3 unstimulated. NT-3 was released from PPy as an initial burst in the first 24 h followed 
by prolonged release over 6 days. The amount of NT-3 incorporated into the polymer was 
determined by the film thickness and polymerization time, with longer growth periods 
incorporating more NT-3[65]. 
This method has been employed in a number of studies in nerve tissue engineering 
applications to be proven as an effective method to deliver NTFs to nerve cells. Richardson  et 
al. used this kind of electrodeposited PPy/tosylate(pTS)/NT-3 platform in Cochlear implants 
(pTS as supporting dopant), and showed that neurites outgrowth from auditory neurons (spiral 
ganglion neurons (SGNs)) grown on this platform is longer than that cultured on a PPy/pTS 
platform, which was equivalent to tissue culture plastic (passive control). ES of PPy/pTS/NT-
3 with a biphasic current pulse, as used in Cochlear implants, significantly improved neurite 
outgrowth from explants. That means this scaffold can provide a biocompatible, low-
impedance substrate for storage and release of NT-3 to help to protect auditory neurons if 
applied to the Cochlear implant, and will enhance neurite outgrowth [66]. A similar work using 
BDNF instead of NT-3 with the same protocol achieved a similar conclusion as above [67]. 
This PPy/pTS/NT-3 system has also been coated on platinum Cochlear implant electrodes for 
in vivo study. When implanted into deafened cochleae, stimulated PPy/pTS/NT-3 coated 
electrodes promoted a slight improvement to neural density, without affecting fibrous tissue 
formation [68]. 
Thompson et al. then further investigated the effect of dual neurotrophins using BDNF and 
NT-3 on this platform. Neurite outgrowth from Cochlear neural explants grown on polymers 
containing both NT-3 and BDNF showed significant improvement over PPy doped only with 
NT-3 or BDNF, due to the synergistic effect of both neurotrophins. Neurite outgrowth was 
further improved when ES was applied on dual neurotrophins incorporated scaffold (Figure 
6) [69]. 
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The following study by Thompson et al. showed that dopant anions were of great importance 
to the electrical deposited PPy/dopant/NTFs platform in their influence on the properties of 
PPy film and release kinetics. Different dopants, sodium salts of pTS, dodecyl 
benzenesulfonate (DBS), poly(styrenesulfonate) (PSS), HA and chondroitin sulfate (CS) and 
the ammonium salt of PMAS, were used in the synthesis of PPy with NT-3 to investigate this 
influence, and the results illustrated that the physical properties (roughness, conductivity) of 
PPy films and kinetics of NT-3 release were both affected by dopants. That is possibly due to 
the difference in surface area or electrochemical properties of PPy films which were caused 
by the size and properties of different dopant molecules. Surprisingly, PPy films doped with 
the smallest dopants (pTS and DBS) were found to have the best conductivity and 
biocompatibility with the neural tissue cultured, and demonstrated the best release kinetics as 
well as neurite outgrowth performance. Instead, natural biomolecule dopants, such as HA and 
CS, did not show any advantage in biocompatibility as assumed [70].  
Kim et al. (D. Martin group) used this method to synthesize PPy/NGF and PEDOT/NGF films 
for a PC 12 cells study. Optical and fluorescence microscopy revealed that PC 12 (rat 
pheochromacytoma) cells can well adhere to and have extended neurites on both NGF-
modified substrates, indicating that the NGF in the polymer film is biologically active.  In 
addition, electrochemical properties study revealed that the NGF-modified CPs substrates 
both showed very low minimum impedance [71]. 
The entrapment of NTFs in CPs via electrical deposition achieved successful interfacial NTFs 
delivery with little passive release and created visible improvement on nerve cell proliferation 
and neurites extension. But it needs a high concentration of NTFs during electrochemical 
deposition to ensure that there were enough NTFs trapped in CPs films. The progressively 
passive release of NTFs into the medium may decrease the bioactivity of NTFs. Tissues/cells 
cannot survive long without additional NTFs supply.   
3.4.1.2. Chemical NTFs Modification on CPs Surface 
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To avoid the passive release of NTFs and the lost of bioactivity of NTFs, another strategy to 
chemically modify the NTFs on CPs surface via chemical reactions was developed. Through 
NTFs incorporation, it was expected that NTFs can be delivered exactly to the injury sites, 
and nerve cell neurite outgrowth and network formation can be enhanced without any external 
NTFs addition via this method[65]. 
Chemical modification of NTFs on CPs scaffold surfaces can be carried out with either 
selected dopants that copolymerize with CPs or modified CPs monomers, even via some 
specific intermediate molecule. NTFs anchored on CPs through chemical modification were 
connected covalently to the scaffold surface and were hardly released from the CPs scaffold 
without ES. NTFs chemically modified on CPs can remain bioactive over a relatively long 
period, thus it avoids NTFs wastage during both the modification procedure and cell culture 
experiments.  
Biotin, which is also known as vitamin B7 or coenzyme R, is a popular intermediate molecule 
used in controlled drug release. Langer et al. used Biotin as dopant in PPy 
electropolymerization, and then incubated Biotin-doped PPy films with streptavidin to form a 
surface capable of attaching any biotin labeled compound. The stability of biotin-doped PPy 
was tested by storing the sample in PBS for 14 days. Results showed that there was no release 
of biotin without activation. Modified biotinylated NGF can bind to the streptavidin and be 
released via ES together with biotin. The stimulated released NGF remained active and 
caused PC 12 neurite outgrowth with no statistical difference when compared to unreleased 
NGF anchored on biotin-doped PPy film and unmodified NGF directly added to cell culture 
medium[72].    
C. E. Schmidt group immobilized NGF on the surface of PPy film surface using an 
intermediate linker provided by a layer of polyallylamine conjugated to an arylazido 
functional group [73]. NGF was fixed to the substrate upon exposure to UV light and activation 
of the azido groups (Figure 7). The immobilization of 0.98ng/mm2 NGF on PPy surface 
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produced similar neurite extension in PC12 cells compared to soluble NGF 50ng/mL. In 
addition, ES using PPy NGF further increased neurite length by 50% with respect to controls 
without stimulation. Cell adhesion was also improved as a consequence of the immobilization 
procedure. This suggested a possible method to enhance both electrical and biological 
stimulation to nerve cells. The only disadvantage of this method is the decrease in 
conductivity of PPy (10-3 – 10-6 S/cm) in comparison with original PPy (10 S/cm) which may 
affect the stability of the PPy NGF film for long term ES.  
To overcome this disadvantage, the Schmidt group developed copolymers of N-hydroxyl 
succinimidyl ester pyrrole (PPy/NSE) and regular pyrrole, which can be immobilized with 
NGF without significantly hindering conductivity (Figure 8). A copolymer containing 50:50 
monomer ratio of pyrrole/pyrrole-NSE was electrochemically deposited and selected for 
further NGF modification for its good conductivity (~8S/cm) and active ester groups for NGF 
immobilization. The active ester groups were stable for up to 5 days. Application of an 
external electrical potential to NGF immobilized PPy films did not cause a significant release 
of NGF nor reduce their neurotrophic activity [74].  
Chemically modified NTFs on a CPs surface showed better controllable ability (less passive 
release, NTFs not consumed) with regards to entrapped NTFs by electrical deposition. 
However, the chemical modification procedure is more complex and normally needs more 
than one step to achieve final products. It is time and efforts consuming. Furthermore, 
chemical modification also needs specific/non-general chemical reactions on both CPs and 
NTFs, even the monomer had to be specifically designed, which is not suitable for clinical 
usage that needs massive amounts of commercial products. 
3.4.2. Incorporation of Cell Adhesion Proteins in CPs 
Physical adsorption of cell adhesion biomolecules is the most often used method in CPs tissue 
engineering work and is performed by dipping the CPs scaffold in cell adhesion biomolecules 
solution for a period of time. The cell adhesion biomolecules used in these works include 
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laminin, collagen, Poly(lysine) etc. Admittedly, this method is easy and has been widely 
employed in bionic labs. However, the thickness of the coating and the amount of cell 
adhesion biomolecules is hard to control and thus may affect the surface interaction between 
the nerve cells and CPs.  
Similar to NTFs, modification of cell adhesion cues can be also achieved by electrical 
deposition entrapment. However, some evidence showed that entrapment of cell adhesion 
laminin peptide together with NGF in PEDOT film decreased the mechanical,   
electrochemical and biological performance of CPs films, although the cell adhesion property 
was improved [23].  
Chemical modification of cell adhesion biomolecules can be achieved by directly binding 
intermediate peptide on CPs surface or by general chemical reactions with specifically chosen 
dopants. A modification of cell adhesion promoting peptide (GRGDS) on the CPs surface was 
made by firstly binding T59, a unique peptide sequence, directly to chloride-doped PPy 
(PPyCl) as a bio-functional linker for covalent binding of RGD. The RGD-modified PPyCl 
was proved to significantly promote PC12 cell adhesion, while no cell adhesion was seen on 
unmodified PPyCl[24]. This method can be applied to immobilize a variety of biomolecules.  
Cell adhesion biomolecules can also be attached on the active functional groups of dopant 
molecule employed in CPs. A study utilized polyglutamic acid as the dopant for further 
modification of the cell adhesion cues polylysine and laminin on PPy surface via standard 
amide coupling reactions. Cell adhesion and neurite extension were found to occur in the 
micro-patterned area where positive guidance cues were attached (Figure 9)[25].  
Wallace’s group recently reported a method using chondroitin sulfate (CS), an extracellular 
matrix molecule bearing carboxylic acid moieties, as dopant in electrochemical deposition of 
PPy. Type I collagen could be bound on carboxylic acid groups covalently and form a fibrillar 
collagen matrix (Figure 10). More PC 12 cells were adhered on PPy substrate due to this 
surface modification and neurite outgrowth was also demonstrated, while ES further enhanced 
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the ability for nerve regeneration[75, 76]. In this work, the cell adhesion biomolecule did not 
serve as dopant, thus would not decrease the physical and chemical properties of CPs.  
3.4.3.Incorporation of Other Dopants and Composites  
The influence of CPs’ properties on nerve cell response was studied using various dopants 
and composites to tune the properties and biocompatibility of CPs. The studies on CPs 
dopants covered a wide range of dopant molecules from small molecule (chloride (Cl), pTS, 
and nitrite (NO3)), polymer dopants (PSS, PMAS), to biomolecule dopants (CS, HA, heparin 
dextran sulfate (DS))[31, 70, 77]. The size and properties of dopants determined the physical, 
chemical and interfacial properties of CPs (roughness, modulus, conductivity etc.), which 
strongly influenced nerve cell activities.  Some biomolecules did not show obvious advantage 
in cellular compatibility, which is attributed to the poor CPs substrates it formed. Thus both 
biological activity of the dopant and its influence on CPs properties need to be considered 
when choosing a CPs scaffold. The aims to synthesize these CPs composites can be classified 
into the following categories: increasing biocompatibility, introducing biodegradability, and 
introducing elasticity into the CPs scaffold [78]. 
Generally, natural biomolecules (HA, chitosan) would be selected as dopants when improving 
the biocompatibility of CPs is necessary. A PPy/HA composite was fabricated by electrical 
deposition of PPy/HA membrane on PPy/PSS substrate. This method retained most of the 
conductivity and electrochemical stability of the scaffold while successfully produced a 
smooth conductive, HA-containing PPy scaffold. These films retained HA on the surface for 
several days in vitro and promoted vascularisation in vivo [79]. 
Meng et al. chemically synthesized PPy/heparin (PPy/HE) nanoparticles through emulsion 
polymerization at different PPy/heparin ratios and added the particles into PLLA chloroform 
solution under stirring to generate PPy/PLLA biodegradable membranes of 102 to103 Ω/ 
square. The existence of HE was verified on the membrane. The conductive membranes 
  
19 
 
containing HE-doped PPy particles   recorded   significantly   increased   electrical   stability, 
cell adhesion, and growth [80]. 
Similar work has been done using chitosan to replace PLLA. 2.5% PPy and 97.5% chitosan 
were mixed to form a biodegradable film for Schwann cells ES. The results showed that the 
PPy/chitosan membranes supported cell adhesion, spreading, and proliferation with or without 
ES. ES applied through the PPy/chitosan composite dramatically enhanced the expression and 
secretion of NGF and BDNF when compared with control cells without ES [81]. 
When biodegradable CPs were needed for in vitro and in vivo applications, copolymerization 
of PPy and degradable block poly(ε-caprolactone) (PCL) and poly(ethyl cyanoacrylate) 
(PECA) could create biodegradable PPy/PCL and PPy/PECA.  The PPy portions of the co-
polymers permit ES whereas the PCL or PECA blocks enable degradation by hydrolysis. The 
studies indicated that these new conductive degradable biomaterials have good 
biocompatibility and support proliferation and growth of PC12 cells in vitro (with and without 
ES) and neurons in vivo (without ES)[82]. However, the conductivities of the scaffold was 
harmed by the copolymerization of degradable blocks. 
The improvements of biodegradable CPs scaffold were achieved by coating PPy onto 
biodegradable polymer scaffolds. Various polymers, including PLGA[83], 
polycaprolactonefumarate (PCLF)[84], oligo(polyethylene glycol)fumarate(OPF)[85]and 
poly(D, L-lactide-co-epsilon-caprolactone) (PDLLA/CL)[86] etc., have been employed as 
degradable scaffold materials. The coating of PPy showed better cell adhesion ability and can 
provide ES to nerve cells and tissues cultured on CPs hybrid scaffolds. Biodegradable 
scaffolds obtained from this way got much higher conductivities but low long-term stability 
due to the poor adhesion between platform polymers and CPs during degradation process. 
This concern was solved by chemical polymerization of monomer with different 
concentrations in a biodegradable polymer solution, followed by precipitation. The surface 
resistivity of the PPy/PDLLA membrane with 3% PPy was as high as 1 x103 Ω/square. The 
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electrical stability was significantly better in the PPy/PDLLA composite than in the PPy 
coated polyester fabrics and sustained a biologically meaningful electrical conductivity in a 
typical cell culture environment for 1000h [87]. This composite was fabricated into NCs for 
further neuroregeneration studies. When PC12 cells are seeded on these NCs and stimulated 
with 100 mV for 2 h, there is a marked increase in both the percentage of neurite-bearing cells 
and the median neurite length. More importantly, when this PPy/PDLLA conduit was used to 
repair a rat sciatic nerve defect it performed similarly to the gold standard autologous graft. 
These promising results illustrate the potential that this PPy/PDLLA conducting composite 
conduit has for neural tissue engineering[88].  
The introduction of elasticity into CPs was mainly realized using silicone. The electrical 
properties of the elastomeric conductors were strongly dependent on their composition, and 
mixtures were identified that provided high and stable conductivity.  In vivo and in vitro 
studies for nerve repair demonstrated the feasibility of the use of conductive elastomers for 
peripheral nerve stimulating electrodes [89]. 
By incorporating different kinds of bioactive molecules, the interfacial “release on demand” 
delivery of NTFs can be achieved and the properties of CPs can be tuned by carefully 
choosing various functional bioactive molecules as dopants, For example, CPs will have 
better cell adhesion ability with collagen and laminin, better biocompatibility with  HA, HE 
and chitosan, better degradability with  PCL and PECA, and become stretchable with silicone.  
One of the concerns of decoration of biomolucules on CPs is that most of these decorations 
affected the conductivity of CPs. These biomolecules dopants did not have π–π coupling 
structures and thus harmed the conductivity of CPs. Also, other isolative additives as 
biodegradable polymers and silicone affected the interaction between the CPs polymer chains 
as well as conductivity. The balance between conductivity and other properties must be 
stringently kept to realize the best neuroregeneration effect. Also, new methods like 
modifying dopants instead of CPs to avoid conductivity loss should be developed for better 
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results.  In addition, the dopants of CPs were limited to anions as the polymer chains were 
positively charged. Cations and neutral molecules cannot be doped on CPs polymer chains 
directly. More specific design and steps were needed which were not good for clinical 
applications.    
3.5. Interfacial surface guidance of CPs in Neuroregeneration 
In general, the strategies for neuroregeneration should address the regrowth of injury neurites, 
the plastic remodelling of neuronal circuitry and/or the regeneration of new nerve cells[90]. 
Therefore, successful scaffold platforms designs should fulfil all needs these three objects 
required. For example, axons regrowth requires overcoming an unfavourable and inhibitory 
environment, and requires proper axonal spatial organization, target recognition and the 
reconstruction of functional synapses. And these requirements can be partially addressed by 
designing proper scaffold platform with micro- and nano- structures. 
To investigate the influence of the structures and scales of micro- and nanostructured CPs, 
various surface topographies including nanofibres, microfibres, nanotubes, micro patterns, 
microlines and 3-D structures were fabricated and served as platform scaffold in 
neuroregeneration. Techniques that were utilized for CPs scaffold fabrication include 
electrospinning, wet spinning, inkjet printing, extrusion printing, electron beam and template 
polymerization. Scales of these scaffolds ranged from 100nm to nearly 1mm and influenced 
nerve cell performance at various scales. Nerve neurite can grow along both aligned 
nanofibres and wet spun microfibres assisted with ES.   
3.5.1. CPs Nanofibres scaffolds  
The use of nanostructured scaffolds in neuroregeneration is primarily due to their abilities to 
promote neuronal adhesion, to recreate an extracellular matrix(ECM) like microenvironment 
and to interact with neuronal membranes at the nanoscale[91]. Although it looks like mico- and 
nano- structured scaffolds can both impact on tissue/cell surface guidance, such as neurites 
outgrowth, orientation and cell immigrations, likely by the bio-mimicry of ECM, the 
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mechanism of the interaction of nerve tissues/cells with supporting scaffolds can only occur at 
nanoscale level. Firstly, the secretion of neural cell adhesion molecules(NCAM, N-cadherin 
and integrins[92]) is sensitive to nanotopography as the adhesion sites on cell membranes are 
mainly in the 5-200 nm range. Furthermore, nerve tissues/cells demonstrated a remarkable 
preference for the rough surfaces which match the size of themselves (nanofibers, nanotubes 
etc.) in neuronal processes including proliferation, neurites growth and orientation[93]. 
Therefore, nanostructured scaffolds were widely investigated to provide interfacial surface 
guidance to nerve tissues/cells.  
Electrospinning is the most common used method to generate CPs nanofibres utilized for 
nerve tissue engineering platforms to mimic the structural and biological function of native 
extracellular matrix as much as possible [26-28]. CPs nanofibres can be obtained by 
electrospinning CPs blended solutions with other polymers such as gelatine, collagen, poly-L-
lactide (PLLA)[26, 94] or by chemically coating a CPs layer onto pre-electrospun biopolymer 
nanofibres[83, 28].  
CPs solutions or dispersions cannot be directly fabricated into nanofibers by electrospinning 
due to the concentration and viscosity restrictions. Additional isolative polymers will be 
added to tune the rheology of CPs. Molamma P. Prabhakaran et al. has mixed doped PANi 
with poly (ε-caprolactone)/gelatin (PG) (70:30) solution for electrospinning to obtain 
PANi/PG nanofibres with diameters of 112 ± 8 nm. Nerve stem cell culture was performed on 
this scaffold and ES through conductive nanofibrous PANI/PG scaffolds showed enhanced 
cell proliferation and neurite outgrowth compared to the PANI/PG scaffolds that were not 
subjected to ES [94]. The following work from this group showed that PANI/PLLA electrospun 
nanofibres demonstrated a quite similar performance to their previous study [26]. 
The addition of supporting materials may affect the conductivities of CPs. Another method to 
avoid conductivity loss was developed by coating CPs on pre-electrospun biomaterials 
nanofibres to create CPs nanofibre structures. The coatings of CPs were often carried out by 
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vapour phase chemical polymerization or solution chemical polymerization. In a study of PPy 
coated nanofibre, PLGA nano-meshes were firstly fabricated via electrospinning then put in 
pyrrole/pTS aqueous solution for chemical polymerization. The reaction was initiated by 
FeCl3 and kept for 24 h at 4
οC to get PPy/PLGA meshes. The results of cell experiments 
showed that PPy/PLGA electrospun meshes enhanced the growth and differentiation of PC12 
cells and hippocampal neurons comparable to non-coated PLGA control meshes.  ES studies   
showed that PC12 cells, exhibited 40–50% longer neurites and 40–90% more neurite 
formation compared to unstimulated cells on the same scaffolds [83].  
While random CPs nanofibres showed promotion effect in nerve neurite outgrowth, the effect 
of aligned nanofibre on neurite extension guidance was studied by a group using vapour phase 
coated PPy on highly aligned nanofibres. Poly(styrene-b-isobutylene-b-sty-rene) (SIBS) and 
FepTS have been electrospun onto a gold coated mylar sheet in a sealed box containing  
pyrrole monomer vapour. PPy was polymerized on highly aligned SIBS/FepTS nanofibres via 
vapour phase polymerization during the electrospinning process.  Cell experiments illustrated 
that neurite outgrowth from PC12 cells could be highly orientated parallel to the aligned 
PPy/SIBS fibres. Physical interactions between the nerve cells and PPy/SIBS fibres were 
observed using atomic force microscopy (Figure 11). These observations indicated a role of 
contact guidance as a mechanism for the observed alignment [28].    
Besides PANi and PPy, PEDOT electrospun nanofibres have also been investigated as nerve 
tissue engineering scaffolds. Electrospun PET nanofibres were coated with PEDOT/pTS using 
vapour phase polymerization. The nanofibres were good platforms for providing cells with a 
substrate for adhesion and proliferation. These conductive scaffolds were used to electrically 
stimulate Ca2+ signaling [36, 95] in SH-SY5Y nueroblastoma cells. Results showed that the 
combination of ES with highly porous and permeable 3D structures provided additional 
functionality to stimulate cells or record cell signaling [96].  
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The increasing demands for combined and complicated interfacial stimulation promoted the 
incorporation of more functional molecules into nanofibres scaffold. Based on the PPy coated 
PLGA nanomesh discussed above [83], NGF was chemically immobilized onto the surface of 
the fibres (Figure 12). These NGF immobilized PPy coated PLGA (NGF/PPy/PLGA) fibres 
supported PC12 neurite formation (28 ± 3 % of the cells) and neurite outgrowth (14.2 μm 
median length), which were comparable to that observed with NGF (50 ng/mL) in culture 
medium (29 ±1.3 %, 14.4 μm). ES of PC12 cells on NGF immobilized PPy/PLGA fibre 
scaffolds was found to further improve neurite development and neurite length by 18% and 
17%, respectively, compared to unstimulated cells on the NGF immobilized fibres. Hence,  
sub-micrometre-scale fibrous scaffolds that  incorporate  neurotrophic and electroconductive  
activities  may  serve  as  promising  neural  tissue  engineering  scaffolds; such  as  nerve  
guidance  conduits[27]. 
3.5.2. CPs Nanotubes 
Another type of nanostructured CPs scaffold, CPs nanotubes,  were designed by Abidian et al. 
to increase charge capacity density (CCD) for stronger and longer ES to nerve cells and 
decrease impedance for better neural signal recording. The hollow structure of nanotubes 
creates more surface areas compared to nanofibres, as well as films, allowing more surfaces 
for electrical charges storage[97], which means high capacitance as well as CCD. The 
impedance of the CPs can be represented by the equation: 
                                                        Z = R +  I (ωL - 1/ωC)                                                   (1) 
Where R is resistance, I is current, L is inductance, C is capacitance and ω is a sinusoidal 
undulation frequency[98]. Therefore, higher capacitance will lead to lower impedance from this 
equation. The PEDOT and PPy nanotubes were created via electrical deposition of CPs on 
pre-electrospun PLA nanofibres followed by removal of the PLA template by dissolving them 
in dichloromethane. Electrochemistry studies on impedance and charge capacity density 
(CCD) illustrated that PPy and PEDOT nanotubes have lower impedance and higher CCD in 
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comparison with their film counterparts. DRG cultured on CPs nanotubes exhibited longer 
neurites length than their film comparison samples. In addition, CPs nanotubes showed long 
term electrochemical stability in CV characterization, illustrating that it can serve as scaffolds 
in long term cell culture and ES experiments [99].  
3.5.3. CPs Nanoporous Scaffold 
The exploitation of nanostructured conductive polymers, is hampered by their low solubility, 
poor mechanical integrity, and difficulty in fabrication. To improve the mechanical strength 
and retain the nanostructures, Cai et al. prepared electrically conductive nanoporous materials 
by coating nanoporous cellulose gels (NCG) with PPy. The resulting NCG/PPy composite 
hydrogels were converted to aerogels by drying with supercritical CO2, giving a density of 
0.41 - 0.53 g cm-3, nitrogen adsorption surface areas of 264 - 303 m2 g-1, and high mechanical 
strength. In vitro studies showed that the incorporation of PPy into an NCG enhances the 
adhesion and proliferation of PC12 cells. ES demonstrated that PC12 cells attached and 
extended longer neurites when cultured on NCG/PPy composite gels with DBSA dopant[100].  
3.5.4. CPs Microfibres Scaffold 
Besides, nanostructures, significant efforts have also been put into the development of 
electroactive hybrid scaffolds at the micrometre scale for the guidance of nerve cell migration 
and neurite outgrowth at certain directions. Nanostructures can create different surface 
morphologies and surface roughness to influence the cells at the nanometre scale while the 
micro-scale scaffold is comparable to a cell body size for the whole cell to attach and migrate 
along the scaffold. 
Wet spinning microfibres conductive scaffold has been studied for its potential to control the 
multiple cues, such as topographic guidance, support, and ES to promote neurite directional 
growth. Biodegradable copolymer PLA:PLGA (75:25) was wet-spun into fibres 
(approximately 30 μm in diameter), and aligned onto gold-coated mylar wrapped around a 
collector spool. The constructs were laid flat to facilitate the galvanostatic deposition of 
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PPy/pTS film, creating a thin layer of PPy/pTS between the biodegradable fibres. Scanning 
electron microscopy (SEM) confirmed the presence of the fibres embedded in the CPs layer   
(Figure 13 A-C). Dorsal root ganglia (DRG) explants cultured on this scaffold demonstrated 
axonal growth and Schwann cell migration followed the path of the polymer fibres on both 
stimulated and unstimulated platforms (Figure 13 E-G). ES enhanced the axonal growth 
significantly over 60% and promoted Schwann cell migration to some extent as well [18].  
Another study on the micrometre scale fibre scaffold utilized a blend of electrically 
conductive PANi and polypropylene (PP) composite fibres as the backbone of encapsulated 
nerve tissue engineering relays. Fibres with around 400 μm diameter were manufactured by 
extrusion through a capillary rheometer and coated with collagen for DRG culture. A high 
density of neurons on the fibre surface (over 700 neurons/mm2) was obtained and resulted in 
robust neurite extension and network formation. After that, this neuron network on fibre 
surface was encapsulated with agarose to form a protective barrier while potentially 
facilitating network stability (Figure 14). These efforts effectively created functional 
electrical interfaces for nerve cells and improved neurocompatibility, high density nerve cell 
adhesion and neurite network formation on micrometre scale fibre surfaces [19].  
3.5.5.CPs  Micro Patterns 
To combine the electrical and topographical cues for the stimulation of nerve cells, 2-D CPs 
micro-patterns have also been developed to function as tissue engineering scaffolds. Gomez et 
al created 1 and 2 μm wide PPy micro channels using electron-beam (e-beam) lithography 
and electrical polymerization. Embryonic hippocampal neurons cultured on patterned PPy 
polarized (i.e., defined an axon) faster on the modified material, with a two-fold increase in 
the number of cells with axons compared to cells cultured on unmodified PPy (Figure 15). 
These topographical features also have an effect on axon orientation but do not have a 
significant effect on overall axon length [20].  
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Micro-patterns can also be created by inkjet printing. Parallel PPy lines (100μm width) have 
been deposited on biocompatible polymer substrate then covered by collagen using a Dimatix 
inkjet printer. PC 12 cells cultured on the substrate could be located on the surface of the 
micro lines and formed a neurite network. ES applied at the ends of the line can promote 
neurite outgrowth and guide the orientation of neurite extension along the printed PPy lines 
[21].  
3.5.6. 3D CPs Nerve Conduits 
To guide nerve tissues/cells recovery at lesion gaps, 3D PPy tubes were made via electrical 
deposition of PPy on wire template with different diameters. After the growth of PPy film, a 
reduction potential applied to the template allowed mechanical dissociation from the electrode 
template, creating a stand-alone PPy tube. Multichannel tubes were also fabricated via the 
same method. The obtained PPy nerve conduits were cut into 15mm lengths and placed in 
transected rat sciatic nerves, and were shown to support nerve regeneration over an 8-week 
time period[101]. 
In summary, due to their inherent electrical conductive properties, reversible electrochemical 
properties, interfacial properties and their cyto-compatibility, CPs successfully provided all 
kinds of interfacial stimulations discussed above [22, 102]. In detail, firstly CPs’ highly 
conjugated carbon backbone and charge transfer ability allow them to provide direct ES to 
nerve tissues/cells cultured on their surface to significantly enhance neurite outgrowth; 
secondly, CPs can be doped with positively charged biomolecules and proteins for surface 
modification purposes which can improve cell adhesion properties and  cell proliferation 
abilities; thirdly, CPs exhibit reversible electrochemical properties to allow the dopants to be 
released from the polymer chains, which illustrate the possibility of “release on demand” 
interfacial NTFs delivery in neuroregeneration; finally, their processability allow them to be 
formed into various geometries or patterns to get additional interfacial properties. Recent 
developments in micro- and nano-scale fabrication techniques of CPs, including laser beam, 
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electrospinning, wet spinning, and inkjet printing, create a series of nanofibres, nanotubes and 
micro dots and lines arrays to promote interaction between neural cells/tissues and materials 
surface.  
The combined interfacial stimulations that CPs can provide made the foreground of CPs 
scaffolds in neuroregeneration quite promising. However, the barrier of transferring CPs into 
clinical ues from laboratory still existed. First of all, the electrochemical stabilities of CPs 
were not as reliable as needed which may result in the failures in interfacial NTFs delivery 
and ES. Environments including temperature, pH values, salts in tissue/cell culture mediums 
can all influence the electrochemical stabilities of CPs. The possible loss of dopants and 
fracture of polymer chains during ES may change the conductivity of the scaffold, which may 
lead to lower stimulation current and weak stimulation effects under the same potentials 
applied. The impendence of CPs would also increase for the same reasons and affected ES 
results or the signal recording results. To avoid this, ES of CPs should be applied in an 
appropriate range to make sure that CPs scaffolds were not overloaded under ES. The 
biodegradability of CPs would be another issue that did not achieve the standard of clinical 
utilization. CPs themselves were not degradable at all. Biodegradable CPs were most often 
created by coating CPs upon biodegradable polymers such as PLGA. The CPs layer broke 
into small pieces with PLGA degradation and the influence of these CPs residues remains 
unknown in vivo, which limited the applications of CPs in clinical application. In addition, a 
great many of CPs devices for neuroregeneration were fabricated via electrochemical 
methods, which is not suitable for massive production, limited the utilization of CPs in 
clinical as well.  
3.6. Bio-interface of Carbon nanotube and Graphene based materials in 
Neuroregeneration 
Graphitic nanomaterials, such as carbon nanotubes (CNTs) and graphene, have gained a great 
deal of interests in the scientific communities due to their novel properties and wide range of 
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potential applications. As these graphitic materials hold similar but enhanced electrochemical 
properties in comparison with CPs, we also discuss the bio-interface effects in 
neuroregeneration that employed CNTs and Graphene based materials in this review.  
Several early studies demonstrated CNTs were capable of serving as the scaffold in nerve 
tissue engineering and can offer ES to nerve cells that are cultured on the CNTs’ surface 
[103].Recent study on the cytotoxicity of CNTs and graphene illustrated that graphene is a 
better choice in nerve regeneration as it had lower cytotoxicity and better physical properties 
valued by PC 12 cells than single wall CNTs [104]. The promotion of nerve stimulation by a 
graphene substrate was studied using a mouse hippocampal culture model by Li et al.. The 
results revealed that graphene substrates exhibited excellent biocompatibility, as cell viability 
and morphology were not affected in comparison with the control specimen. In addition, 
neurite numbers and average neurite length on graphene were significantly enhanced during 
2-7 days after cell seeding compared to tissue culture polystyrene (TCP) substrates [105].   
A 3-D graphene foam electrode has been recently reported as a promising candidate for nerve 
stem cell scaffold as it may incorporate topographical, chemical and electrical cues in the 
same scaffold to provide an environment for neural tissue regeneration that is superior to 
conventional inert biomaterials (Figure 16). It was found that three-dimensional graphene 
foams (3D-GF) can not only support NSCs growth, but also keep cells at an active 
proliferation state with regulation of Ki67 expression than that of two-dimensional graphene 
films. Meanwhile, phenotypic analysis indicated that 3D-GFs can enhance the NSCs 
differentiation towards astrocytes and especially neurons [106]. 
In addition, CNTs and graphene based materials can enhance the properties of CPs in 
CPs/graphitic materials hybrid scaffold. CNT doped PEDOT showed an enhancement in 
electrical stability and conductivity compared to PEDOT, while neuron cellular activities 
were more or less the same [107].  PPy/graphene oxide (GO) composites demonstrated 
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significantly lower impedance than Pt electrode and pure PPy when used as neural probes 
materials [108].  
4. Summary and Criteria  
The importance of bio-interface of polymer based biomaterials in neuroregeneration was 
proven by a series of investigations despite the existence of weakness and imperfection. To 
better clarify what kinds of criteria that an ideal biocompatible polymers interface should 
achieve, the advantages and disadvantages of current developed polymer scaffolds discussed 
above are summarized in Table 2.  
We can easily conclude from Table 2 what are the properties that a successful biocompatible 
polymer scaffold should possess (Table 3).  These biocompatible polymers should be 
biocompatible, biodegradable to ensure their long term clinical usage. In addition, these 
polymers should have specific physical, electrical, interfacial and biological properties to 
serve stably in a cell culture environment, provide interfacial ES, and interfacial delivery of 
NTFs to a lesion site when necessary. These criteria should be achieved by careful design and 
synthesis of the polymer scaffold which can successfully mimic an in vivo micro-
environment, which is composed of cells, support scaffolds, growth factors and the 
extracellular matrix, and plays an important role in regulating neurogenesis, survival and 
regeneration of nerve cells [109]. 
Flaws exist in nearly all current techniques more or less; such as synthetic biodegradable 
polymers’ poor cell attachment ability and uncertain long term stability of CPs. The direction 
for future development of bio-interfaces of polymer based materials in our expectations is to 
address the criteria we concluded in Table 2 in a single scaffold; as many as possible. To 
achieve this target, tuning polymer properties using hybrid scaffold with multiple 
modification methods should be considered.  For example, a novel scaffold like cell adhesion 
hydrogel coated NTFs modified CPs microfibres can combine ES, cell attachment ability and 
NTF delivery together for a complicated stimulation to nerve cells and tissues. 
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5. Perspectives 
Success gained till now in the bio-interface of biocompatible polymers for neuroregeneration 
does not mean that the application of novel biocompatible polymer scaffolds clinically is just 
around the corner. Actually, some doubts still exist concerning this kind of material. For 
example, an often used method to create a biodegradable CPs scaffold is the coating of CPs 
on the outer surface of a biodegradable polymer such as PLGA. However, nobody has 
investigated about what happens after the CPs disintegrate with PLGA degradation; ie how 
will these small CPs pieces be discarded and excreted, in in vivo experiments. Also, whether 
these CPs pieces are completely unharmful to the human body is still in doubt. Another 
concern for CPs scaffolds in clinical use is their long-term stability, including both chemical 
stability in vivo and electrical stability to maintain ES for long period implantation. In 
addition, whether long term implantation of the CPs scaffold will result in rejection by the 
body has no conclusion either.  
Thus we assume that in the recent future, investigations on the bio-interface of biocompatible 
polymer scaffolds will focus on the resolution of these problems to bridge the gaps between 
lab research activity and clinical application. In particular, the reliability of biomaterials in 
neuroregeneration needs to be evaluated more intensively before medical applications.  The 
evaluation is not only to study the direct responses from animals but also to build reliable 
models for analysis, thus offering greater knowledge to rationally improve and/or redesign 
biomaterials. Composing novel engineered nanostructures or nanomaterials to enhance 
multifunctionality and/or reliability is another aspect that should be valued. Materials design 
and exploration is the key method to solve the problems that exist concerning 
biocompatibility/ biodegradability. More attention will be paid to long term in vivo 
compatibility testing of novel scaffolds, and the possibility of scalable massive commercial 
production of polymer scaffolds. The translation of research output to commercial therapy 
products will be the first priority in all.  
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Figure 1. The growth of NSCs on the HA hydrogel composite for 5 days. (a, b) The 
fluorescent staining of nestin showed the NSCs (green) adhered on the gel, grew well and 
spread widely along the wall of the scaffold (a overall view), extending long neurites (b, high 
magnification). (c) The hydrogel showed good biocompatibility and support for NSCs by 
SEM. (d) The proliferation array by CCK-8 showed the NSCs grew faster on the hydrogel 
composite than on the HA hydrogel control (*p<0.05)[29]. 
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Figure 2. A) Micrograph of a typical NC (10 x magnification). B) Micrographs of cross-
sections of NC in the dry state and after swelling to equilibrium (20 x magnification)[53]. 
 
 
 
Figure 3. (a) Scanning electron micrograph of the nerve conduit which consists of a PGA–
collagen tube filled with collagen sponge; (b) Suture methods and intraoperative view after 
implantation of a PGA–collagen tube[54]. 
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Figure 4. Chemical structures of (a) PANi; (b) PPy and (c)PEDOT-PSS 
 
(a)
(c)
(b)
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Figure 5. PC 12 cell differentiation on polypyrrole without (A) and with (B) application of an 
electric potential. Bar = 100 μm[22]. 
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Figure 6. Representative images of cochlear neural explants grown on PPy/pTS polymers 
with and without neurotrophin. Neurites were visualised by immunocytochemistry with a 
neurofilament-200 primary antibody and a fluorescent secondary antibody (green). Cell nuclei 
are labelled with DAPI (blue). In the absence of neurotrophin (PPy/pTS), very few neurites 
were observed from explants, while explants grown on PPy/pTS containing neurotrophin 
demonstrated increased numbers of sprouting neurites. A greater number of neurites per 
explant were observed on explants grown on the electrically stimulated PPy films (right). 
These images were taken after 4 days of explants culture. Scale bar is 200 µm and the same 
for all images[69]. 
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Figure 7. Scheme of the NGF immobilization process. PAA was conjugated to an azido 
compound (PAA-azido). This conjugate was cast twice on PPy, followed by casting of NGF. 
UV light exposure promoted the formation of covalent bonds via the azido groups, 
immobilizing NGF to PPy[73]. 
 
 
Figure 8. (a) Schematic of the pyrrole-NSE synthesis (3). 1-(2-Cyanoethyl)pyrrole (1) was 
converted to 1-(2-carboxyethyl)pyrrole (2), followed by the NHS substitution at the carboxyl 
group. (b) Electrochemical synthesis of the copolymers of pyrrole and pyrrole-NSE in 
acetonitrile with tetrabutylammonium perchlorate (TBA-ClO4) as the dopant. PPy/NSEx 
indicates the copolymer which is synthesized with x mol% of pyrrole-NSE from a 50 mM 
total monomer concentration in the polymerizing solution [74].  
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Figure 9. Phase contrast and fluorescent images of DRG adhered to a surface of PPy[pGlu]–
X where X=(a) pLys, (b) Lmn and (c) pLys–Lmn. The cells were fixed at 2 days (a and c) or 
at 12 days (b) after plating. Neurites stained positive for GAP-43 (green fluorescence). Cell 
nuclei were labelled with DAPI (blue fluorescence). All images were taken at 10× 
magnification and thus, the 200 μm scale bar in (b) applies to all images shown[25]. 
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Figure 10. AFM micrographs of PPy/CS/Col film (A), amplified area on PPy/CS/Col film 
without collagen fibers (B) and pristine PPy/CS film (C) in PBS. Blue arrow-large fibrous 
structure; Black arrow - smaller individual fibres[76]. 
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Figure 11. (A) Optical and (B) corresponding AFM images of the boxed region in (A) 
showing a neurite (arrows) extending along a PPy/SIBS fibre (black asterisks). Scale bar in (A) 
= 20 μm. Scale bar in (B) = 5 μm. (C) High-resolution AFM image showing small finger-like 
lateral outgrowths (arrows) making contact with a PPy/SIBS fibre (black asterisks). Scale bar 
in (C) = 1 μm[28]. 
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Figure 12. A. NGF/PPy/PLGA provides multiple cues for neurite outgrowth as the scaffolds 
deliver submicrometer-scale fibrous features, electrical conductivity, and neurotrophic 
activity. B. Schematic for fabricating NGF immobilized PPy/PLGA fibers (NGF/PPy/PLGA). 
i) Electrospun PLGA nanofibers were coated with PPy and PPy(COOH), producing 
PPy(COOH)/PLGA. ii) NGF (represented as circles) was chemically immobilized onto 
PPy(COOH)/PLGA[27]. 
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Figure 13. SEM images (A–C) reveal a relatively smooth PPy surface, in which PLA: PLGA 
fibers are embedded. Tissue culture chambers were attached to the scaffold surface to 
facilitate DRG growth and stimulation (D). Axon growth (arrows) and Schwann cell (arrow 
heads) migration is observed on both the biodegradable fibers (E and F) and the PPy/pTS 
surface (G). Fluorescent microscopy images (E–G) demonstrate that axonal growth and 
Schwann cell migration follow the path of the embedded polymer fibers on both stimulated 
and unstimulated scaffolds. Scale bars = 100 μm (A), 20 μm (B), 5 μm (C), and 50 μm (E–
G)[18]. 
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Figure 14. Tissue-engineered neural-electrical relays. Small diameter (<400 μm) electrically 
conducting PA–PP fibers were chosen as the electrical interface due to their mechanical 
compliance and tailored conductive properties (a). PANi–PP fibers were processed to permit 
neuronal growth and network formation directly on the fibers (b). Then, these biohybridized 
neural-conductive fibers were encapsulated with a bio-inert hydrogel to form a protective 
barrier while potentially stabilizing the network in intimate contact with the PANi–PP (c). A 
multitude of relays may be used in parallel to create complex interface microsystems, with the 
alternate end of the PANi–PP fiber projecting to a processing device for signal filtering, 
amplification and output (d). These ‘wet’ biohybrid neural interface systems may be used as 
investigative platforms in vitro or as biohybrid relays in vivo[19]. 
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Figure 15. From left to right: phase-contrast, fluorescence, and SEM microscopy images, of 
hippocampal neurons on PPy. A–C) Cells cultured on 2 μm wide and 200 μm deep 
PPymicrochannels; D–F) cells cultured on unmodified PPy. The green labelling (Alexa 488) 
corresponds to Tau-1 (axonal marker) immunostaining. Cells polarized more readily on 
microchannels than on unmodified PPy. The scale bar is 20μm (A, B, D, E) and 5μm (C, F)[20]. 
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Figure 16. NSCs adhesion and proliferation on 3D-GF scaffold. Low- (a) and high- (b) 
magnified SEM images of NSCs cultured on 3D-GFs under the proliferation medium. The 
inset illustrates the interaction between the cell filopodia and 3D-GF surface. (c) Cell viability 
assay of NSCs on 3D- GFs after 5 days of culture as determined by live/dead assay, live cells 
are stained green and dead cells are red, white arrow points to dead cell. The lower right inset 
depicts the percentage of live cell on 2D graphene films and 3D-GFs. (d) Fluorescence images 
of NSCs proliferated on 3D-GFs for 5 days, immunostaining markers were nestin (green) for 
neural stem cells and DAPI (blue) for nuclei. (e) NSCs were double-immunostained with anti-
Ki67 (red) and anti-nestin (green) antibodies, Ki67 is a marker for cell proliferation. (f) 
Western Blot analysis of Ki67 expression on 2D graphene films and 3D-GFs. The Data are 
presented as mean ± standard error (s. e. m.), *p < 0.05, **p< 0.01[106]. 
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Table 1. Most widely studied materials for nerve conduit with related properties and selected 
studies where they were used[44]. 
NC polymers Characteristics References 
Silicone:poly(dimethylsiloxane) 
Highly elastomeric polymer, non-biodegradable, bioinert, 
impermeable, hydrophobic 
[45, 48] 
PGA: poly(glycolide) 
Aliphatic polyester, biodegradable by hydrolysis, Commercial NC 
approved by FDA 
[34] 
PHB: poly(3-hydroxybutyrate) Aliphatic polyester, biodegradable by hydrolysis [49] 
PLA: poly(L-lactide) acid 
Aliphatic polyester, very slowly biodegradable 
by hydrolysis 
[35] 
PLGA:poly(DL-lactide)co-glycolide 
Aliphatic polyester, slowly biodegradable 
by hydrolysis 
[29, 50] 
Chitosan:b-(1-4)-linked D-glucosamine Polysaccharide, enzymatically degradable [50] 
PHEMA-MMA:poly(2-hydroxyethyl 
methacrylate-co-methyl methacrylate) 
Hydrogel-forming polymer, nonbiodegradable, 
stiffness in the range of nerve tissue 
[51] 
Polyester urethane Elastomeric polymer, biodegradable [52] 
 
Table 2. Summary of advantages and disadvantages of biocompatible polymer scaffolds. 
Polymer scaffolds Advantages Disadvantages 
Biodegradable polymers 
Biocompatible; 
Biodegradable; 
Processable ; 
Not conductive 
Biodegradable 
polymers 
Synthetic biodegradable 
polymers 
Controllable structure; 
Controllable release period; 
Hydrophobic; 
Poor cell attachment ability; 
Harsh preparation conditions; 
Harmful to NTFs during preparation. 
Natural biodegradable 
polymers 
Gentle preparation 
conditions; 
Not harmful to NTFs. 
Good cell attachment ability 
Burst release of NTFs in initial stage. 
 
CPs 
 
Conductive; 
Low impendence; 
Good cell attachment ability. 
Non-degradable 
Poor long term stability 
CPs 
Electrochemically 
deposited 
Fast and one step 
polymerization; 
Less excessive by-products; 
Scale limitation; 
Dimension limitation. 
Chemically polymerized 
Support scalable fabrication; 
Highly processable; 
Can be fabricated into 
multiple structures 
Time and efforts consuming compared to 
electrodeposited CPs film; 
Excessive reactants and by-products may 
still exist. 
Graphitic materials  
Nanostructures 
Highly conductive 
Electrochemical stability 
Long term cyto compatibility in doubt. 
 
 
Table 3. Criteria for ideal biocompatible polymer scaffolds. 
Properties Criteria 
Biocompatibility Compatible with neuron cells and in vivo environment 
Biodegradability 
Ability to decompose in both in vitro and in vivo environments 
Decomposition products not harmful 
Physical Interface 
Stability in cell culture environment; 
Ability for nanoscale and microscale fabrication to generate topographical stimulation; 
Low hardness. 
Electrical Interface 
High conductivity; 
Low impendence; 
Electrochemical stability; 
Biological Interface 
Good cell attachment and guidance ability; 
Ability to deliver NTFs; 
Ability to promote cell proliferation and neurite outgrowth. 
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This paper reviews the studies in the bio-interface of polymer based materials for 
neuroregeneration, discussing various interfacial stimulation methods (interfacial NTFs 
delivery, surface guidance, electrical stimulation and molecules decoration) that biopolymers 
can provide to lesion neural cells/tissues, and proposes the criteria and perspective of bio-
interface of polymer for neuroregeneration for future development. 
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